N. Zealand LCT Co-Founder Sees Insulin-Making Pig Cells In 2013
This article was originally published in PharmAsia News
Executive Summary
New Zealand co-founder of Living Cell Technologies expects a pig-cell treatment for Type 1 diabetes to reach the market in about two years